These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12856536)

  • 21. Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition.
    Ishii K; Lippa C; Tomiyama T; Miyatake F; Ozawa K; Tamaoka A; Hasegawa T; Fraser PE; Shoji S; Nee LE; Pollen DA; St George-Hyslop PH; Ii K; Ohtake T; Kalaria RN; Rossor MN; Lantos PL; Cairns NJ; Farrer LA; Mori H
    Neurobiol Aging; 2001; 22(3):367-76. PubMed ID: 11378241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression in Alzheimer's disease.
    Ermak G; Davies KJ
    Drugs Today (Barc); 2002 Jul; 38(7):509-16. PubMed ID: 12582468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.
    Campion D; Dumanchin C; Hannequin D; Dubois B; Belliard S; Puel M; Thomas-Anterion C; Michon A; Martin C; Charbonnier F; Raux G; Camuzat A; Penet C; Mesnage V; Martinez M; Clerget-Darpoux F; Brice A; Frebourg T
    Am J Hum Genet; 1999 Sep; 65(3):664-70. PubMed ID: 10441572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
    Steiner H; Capell A; Leimer U; Haass C
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):266-70. PubMed ID: 10653281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.
    Scheuner D; Eckman C; Jensen M; Song X; Citron M; Suzuki N; Bird TD; Hardy J; Hutton M; Kukull W; Larson E; Levy-Lahad E; Viitanen M; Peskind E; Poorkaj P; Schellenberg G; Tanzi R; Wasco W; Lannfelt L; Selkoe D; Younkin S
    Nat Med; 1996 Aug; 2(8):864-70. PubMed ID: 8705854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Alzheimer's disease. Present and future role of genetics].
    Roks G
    Tijdschr Gerontol Geriatr; 2003 Feb; 34(1):13-20. PubMed ID: 12629906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular genetics of Alzheimer's disease.
    Goate AM
    Geriatrics; 1997 Sep; 52 Suppl 2():S9-12. PubMed ID: 9307578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recent advances in the studies on Alzheimer's diseases].
    Tsuji S
    Rinsho Shinkeigaku; 1998 Dec; 38(12):983-7. PubMed ID: 10349334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presenilin function in APP processing.
    Annaert W; Cupers P; Saftig P; De Strooper B
    Ann N Y Acad Sci; 2000; 920():158-64. PubMed ID: 11193144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular genetics of Alzheimer's disease].
    Akinori M; Ryozo K
    Tanpakushitsu Kakusan Koso; 2005 Dec; 50(16 Suppl):2122-7. PubMed ID: 16411440
    [No Abstract]   [Full Text] [Related]  

  • 32. [Gene diagnosis of Alzheimer's disease and Parkinson's disease].
    Tanaka S
    Rinsho Byori; 2002 Oct; 50(10):965-9. PubMed ID: 12451676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monogenic determinants of familial Alzheimer's disease: presenilin-2 mutations.
    Renbaum P; Levy-Lahad E
    Cell Mol Life Sci; 1998 Sep; 54(9):910-9. PubMed ID: 9791533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease.
    Mathews PM; Cataldo AM; Kao BH; Rudnicki AG; Qin X; Yang JL; Jiang Y; Picciano M; Hulette C; Lippa CF; Bird TD; Nochlin D; Walter J; Haass C; Lévesque L; Fraser PE; Andreadis A; Nixon RA
    Mol Med; 2000 Oct; 6(10):878-91. PubMed ID: 11126202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice.
    Citron M; Westaway D; Xia W; Carlson G; Diehl T; Levesque G; Johnson-Wood K; Lee M; Seubert P; Davis A; Kholodenko D; Motter R; Sherrington R; Perry B; Yao H; Strome R; Lieberburg I; Rommens J; Kim S; Schenk D; Fraser P; St George Hyslop P; Selkoe DJ
    Nat Med; 1997 Jan; 3(1):67-72. PubMed ID: 8986743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of new presenilin gene mutations in early-onset familial Alzheimer disease.
    Tedde A; Nacmias B; Ciantelli M; Forleo P; Cellini E; Bagnoli S; Piccini C; Caffarra P; Ghidoni E; Paganini M; Bracco L; Sorbi S
    Arch Neurol; 2003 Nov; 60(11):1541-4. PubMed ID: 14623725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic study of familial cases of Alzheimer's disease.
    Kowalska A; Pruchnik-Wolińska D; Florczak J; Modestowicz R; Szczech J; Kozubski W; Rossa G; Wender M
    Acta Biochim Pol; 2004; 51(1):245-52. PubMed ID: 15094846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress toward valid transgenic mouse models for Alzheimer's disease.
    Guénette SY; Tanzi RE
    Neurobiol Aging; 1999; 20(2):201-11. PubMed ID: 10537029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics of Alzheimer's disease.
    Lannfelt L
    Acta Neurol Scand Suppl; 1996; 168():25-7. PubMed ID: 8997415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.
    Dewachter I; van Dorpe J; Spittaels K; Tesseur I; Van Den Haute C; Moechars D; Van Leuven F
    Exp Gerontol; 2000 Sep; 35(6-7):831-41. PubMed ID: 11053674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.